About this trial
There is pre-existing evidence that probiotics could be useful in the improvement of ileus rates. One metaanalysis of 30 studies demonstrated a reduction in the prevalence of post-operative ileus as determined by time to flatus, time to defecation, as well as postoperative abdominal distension (PMID:37373843). More broadly in gastrointestinal surgery, a meta-analysis of 21 randomised controlled trials similarly affirmed the speedier recovery of gastrointestinal function after surgery when probiotics were administered (PMID: 35231076). In spite of these advantages, the routine use of probiotics perioperatively for colorectal cancer surgery is not performed in Singapore. We therefore seek to perform a trial to investigate whether probiotic administration perioperatively may reduce post operative ileus rates.
Eligibility criteria
Qualifiers
undergoing elective colorectal cancer surgery in which an oncologic resection is planned
age between 21 and 99 years at the time of consent
willing to consider oral nutritional supplementation
on an early recovery after surgery (ERAS) pathway
Disqualifiers
patients with known contraindications to probiotic use
patients undergoing emergency surgery
taking any other form of probiotics
taking oral antibiotics within 7 days of commencement of study
Trial design
Treatments tested in this trial
- Nestle Isocal
- Nestle Boost Optimum